BBNX | Beta BionicsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$15.10
-$0.80 (-5.03%)

Beta Bionics (BBNX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2026, and the two have been drifting apart, yet a death cross is projected within 30 bars. Price sits between the 50 and the 200 on the daily and below both on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $15.10 vs 50 $18.95 / 200 $14.79
Projection
Death cross estimated in 20 to 30 bars
Test
No active test
Last cross
Golden cross 1 Sep 2026 ยท projected 3 bars out ยท tested 2 bars

Weekly

No weekly data

Cross history

2
crosses on record since 2026
1 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Sep 2026Golden steepdaily3 bars out2 bar cross test
27 Feb 2026Death steepdaily29 bars outNot tested

About BBNX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$19.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2026
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.